Histologically confirmed untreated early-stage non-small cell lung cancer (T1-2N0M0), or recurrent disease (rT1-2N0M0) that is inoperable or where the patient is unwilling to undergo surgery.
Serum creatinine ≤ 1.25 times the upper normal limit (UNL) or creatinine clearance ≥ 60 ml/min.
Serum bilirubin ≤ 1.5 times UNL, AST (SGOT) and ALT (SGPT) ≤ 2.5 times UNL, alkaline phosphatase ≤ 5 times UNL.
FEV1 ≥ 0.5 L.
Normal CB6 range.
The patient and their family agree and sign the informed consent form.
You may not be if
Any other disease or condition that contraindicates radiotherapy (e.g., active infections, within 6 months post-myocardial infarction, symptomatic heart disease including unstable angina, congestive heart failure, or uncontrolled arrhythmias).
Pregnant or breastfeeding women, women who have not undergone pregnancy testing, and pregnant individuals.
Individuals with substance abuse issues, chronic alcoholism, or AIDS.
Individuals with uncontrollable seizures or loss of self-control due to psychiatric disorders.
Individuals with a history of severe allergies or specific sensitivities.
Clareo Health | Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung Cancer
